Written by Klarity Editorial Team
Published: May 19, 2026

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can prescribe anxiety medications through telehealth — or you’re considering joining a platform like Klarity Health to treat patients remotely — the short answer is yes. But the real answer depends on your license type, the state(s) you practice in, and understanding the federal and state rules that govern controlled substance prescribing.
This guide breaks down exactly what you can do as a prescriber treating anxiety via telehealth in 2026, with real details on scope of practice, state regulations, and what it means for your practice economics.
Here’s what most providers don’t realize: the COVID-era flexibility that allowed you to prescribe controlled substances (including benzodiazepines for anxiety) via telehealth without an initial in-person visit is still in effect through December 2026.
The DEA and HHS extended these rules specifically to prevent a ‘telemedicine cliff’ where millions of patients would suddenly lose access to their medications. In 2024 alone, over 7 million controlled substance prescriptions — for anxiety, ADHD, and other conditions — were written via telemedicine under these flexibilities.
What this means for anxiety prescribers:
The catch? The DEA is working on permanent regulations expected by late 2026. Those rules may reinstate some requirements or introduce a special telemedicine registration. Stay alert to those changes — but for now, you have operational clarity through at least end of 2026.
State rules still apply on top of federal baseline. Some states have additional telehealth prescribing requirements or restrictions. Let’s break those down by the key markets.
Psychiatrists (MD/DO): Full authority to prescribe any anxiety medication via telehealth. No special state restrictions beyond standard of care. California has strong telehealth parity laws (AB 744), so private insurers must pay you the same for virtual visits as in-person.
PMHNPs: California just went through a major shift. Historically one of the most restrictive states for nurse practitioners, AB 890 created a pathway to independence starting in 2023.
Here’s how it works:
If you’re a newer PMHNP in California without these certifications, you still need standardized procedures with a supervising physician to prescribe. But the path to independence is now clear, which is a huge change for California providers.
Bottom line for CA: Psychiatrists have always practiced freely; PMHNPs are catching up through the new 103/104 system. By 2027, expect more fully independent PMHNPs in California’s telehealth market.
Psychiatrists: Complete prescribing authority via telehealth. Texas specifically prohibits telemedicine treatment of chronic pain with controlled substances, but that doesn’t apply to anxiety treatment — you’re good to prescribe benzodiazepines for panic disorder or GAD via video.
PMHNPs: Texas remains one of the stricter states. You must have a Prescriptive Authority Agreement with a physician to prescribe anything. More importantly, Texas limits NP prescribing of Schedule II controlled substances to hospital settings, hospice, or terminally ill patients.
For anxiety treatment, this mostly matters if you’re treating comorbid conditions. Benzodiazepines (Schedule IV) are fine for PMHNPs to prescribe under their agreement. But if you need to prescribe a stimulant for co-occurring ADHD, you can’t do that in an outpatient setting in Texas as an NP.
The collaboration requirement: Your supervising physician doesn’t need to co-sign every prescription in real-time, but they must be available for consultation and conduct periodic chart reviews. Texas also limits one physician to supervising 7 APRNs at once.
Practical reality: Many established psychiatrists in Texas work with PMHNPs in their practice under these agreements. On a telehealth platform, you’d need that physician relationship formalized. There’s no independent practice pathway for NPs in Texas yet — legislative efforts have repeatedly stalled.
Bottom line for TX: Psychiatrists practice freely; PMHNPs need physician oversight and face Schedule II limitations. If you’re an NP considering Texas telehealth, make sure the platform has physician collaboration infrastructure in place.
Psychiatrists: Full authority. Florida has an interesting rule: the state generally prohibits telehealth prescribing of Schedule II controlled substances, except when treating psychiatric disorders, inpatient care, hospice, or nursing home residents. This carve-out explicitly allows you to prescribe stimulants or other Schedule II meds for mental health conditions via telehealth.
For anxiety specifically (where you’re usually prescribing Schedule IV benzos, not Schedule II), there’s no issue. You can prescribe via telehealth as you would in-person. Must check the state PDMP (E-FORCSE) before prescribing controlled substances.
PMHNPs: Florida requires written protocols with a supervising physician for NP practice. The state created a limited independent practice category in 2020, but it’s only for primary care NPs — psychiatric NPs are excluded.
Here’s the key detail: Florida limits NPs to a 7-day supply of Schedule II controlled substances, unless you’re a psychiatric nurse practitioner prescribing for a mental health disorder. That exception means you can prescribe more than 7 days of controlled anxiety medications when appropriate.
The formulary system: Florida NPs must complete additional training and be filed with the Board to prescribe controlled substances. Your written protocol with a physician must outline which medications you’re authorized to prescribe.
Practical reality: A Florida PMHNP can manage SSRI/SNRI therapy fairly independently day-to-day under their protocol. Starting a patient on a benzodiazepine requires it to be within your protocol scope, and your supervising physician should be aware. Many psychiatric practices structure these protocols broadly to give NPs clinical autonomy while maintaining the legal oversight.
Bottom line for FL: Psychiatrists have full telehealth authority with the psych disorder exception for Schedule II. PMHNPs need physician protocols but get reasonable flexibility for anxiety prescribing under the psych NP exception to quantity limits.
Psychiatrists: Full independent practice and prescribing authority via telehealth. Must check the iSTOP PDMP before every controlled substance prescription — New York has one of the strictest PDMP mandates in the country.
PMHNPs: New York is now a full practice authority state. As of April 2022, NPs no longer need a written practice agreement or collaborative relationship with a physician. You can open your own practice, join a telehealth platform, and prescribe any anxiety medication completely independently.
The 2022 law (NP Modernization Act) removed even the experienced-NP collaborative requirement that existed since 2015. This puts New York PMHNPs on near-equal footing with psychiatrists from a legal authority standpoint.
The only real differences:
Bottom line for NY: This is one of the best states for PMHNP practice. If you’re considering telehealth and hold a New York license, you have full prescribing autonomy for anxiety treatment. The state also has strong telehealth parity laws ensuring equal insurance reimbursement.
Psychiatrists: Independent practice and full prescribing authority via telehealth. PA doesn’t have a comprehensive state telehealth statute, but providers follow federal rules and professional board guidance without additional state restrictions.
PMHNPs: Pennsylvania requires a collaborative agreement with a physician for your entire career as an NP. No pathway to independence has passed yet, despite repeated legislative attempts.
The collaboration must specify what drug categories you can prescribe. The physician must review at least 10% of your charts, and 100% of Schedule II prescriptions within 24 hours. For anxiety treatment with benzodiazepines (Schedule IV), you have more flexibility, but if you’re prescribing stimulants for comorbid ADHD, that requires immediate physician oversight.
Practical reality: One physician can collaborate with up to 4 NPs. Many psychiatric practices structure these relationships so the NP has day-to-day autonomy with the psychiatrist available for consultation on complex cases. For telehealth platforms, PA-based NPs need that formal collaboration in place.
Bottom line for PA: Psychiatrists practice independently; PMHNPs need physician collaboration with no current path to autonomy. If you’re an NP, factor in finding a collaborating psychiatrist (or joining a platform that provides one) before you can practice in PA.
Psychiatrists: Full independent prescribing via telehealth. Illinois has strong telehealth parity laws ensuring equal insurance reimbursement.
PMHNPs: Illinois offers a unique middle ground. You start with required physician collaboration, but after 4,000 clinical hours plus 250 CE hours post-graduation, you can apply for Full Practice Authority.
Here’s the nuance: Even with FPA, Illinois requires a one-time physician attestation for prescribing Schedule II narcotics and benzodiazepines. Essentially, a physician must formally acknowledge that you’ll be prescribing these controlled substances. After that initial sign-off, you can prescribe them independently.
For newer NPs: Without FPA, you need a collaborative agreement where the physician explicitly delegates controlled substance prescribing authority and conducts periodic reviews.
Practical reality: By 2024-2025, many experienced Illinois PMHNPs have obtained FPA licenses. The state also requires a separate Illinois controlled substance license in addition to your DEA registration.
Bottom line for IL: Psychiatrists practice freely; PMHNPs have a clear pathway to near-independence after a few years of experience. The physician attestation requirement for benzos is a minor administrative hurdle, not ongoing supervision.
The question providers ask: ‘Can a nurse practitioner prescribe anxiety meds?’
Yes — PMHNPs can prescribe anxiolytics including controlled substances in all 50 states. But how they can prescribe varies dramatically based on state practice authority.
The three-tier system:
Full Practice Authority (FPA) States:
Reduced Practice States:
Restricted Practice States:
The controlled substance layer: Even in FPA states, all NPs need DEA registration to prescribe controlled substances. Some states (like Texas and Florida) add extra restrictions on Schedule II prescribing by NPs. Schedule IV benzodiazepines are generally accessible to NPs who have prescriptive authority in their state, but always under the rules of their collaboration or FPA status.
Training differences matter: Psychiatrists complete 8+ years of post-college training (4 years med school + 4 years residency). PMHNPs typically complete 2-3 years of graduate-level training after their nursing degree. Studies show PMHNPs provide effective medication management for routine anxiety and depression cases with outcomes similar to psychiatrists, but the scope of training difference drives some of the regulatory caution in restricted states.
The business reality: On telehealth platforms, psychiatrists can typically join and start seeing patients in any state where they hold a license, with no additional provider relationships needed. PMHNPs in restricted states need either platform-provided physician collaborators or must bring their own, adding complexity to multi-state practice.
Let’s talk numbers, because understanding reimbursement determines whether telehealth anxiety treatment is economically viable for you.
Medicare pays surprisingly well for psychiatric medication management:
Telehealth parity: Through at least end of 2024 (and likely through 2025-2026 per recent legislation), Medicare pays the same rate for telehealth visits as in-person. This was temporary during COVID but has been repeatedly extended.
The in-person rule caveat: Medicare implemented a requirement that tele-mental health patients have an in-person visit within 6 months initially and annually thereafter (for non-rural patients). Congress has delayed enforcement of this rule multiple times. As of early 2026, it’s not being enforced, but watch for updates — if it goes into effect, pure telehealth practices may need to add an in-person component for Medicare patients.
State-run, so rates vary significantly — generally 50-60% of Medicare rates:
The volume trade-off: Medicaid pays less per visit, but patient volume can be high. Many patients with anxiety — particularly those with socioeconomic stressors or co-occurring conditions — are Medicaid-insured. Most states now permanently allow psychiatric telehealth for Medicaid and reimburse equally to in-person.
Platform consideration: Some telehealth platforms focus on Medicaid volume with efficient scheduling to make the economics work despite lower per-visit rates.
Private insurers typically pay 100-150% of Medicare rates. A 99213 med check might reimburse $100-$120 from commercial plans. Many states have telehealth parity laws requiring insurers not to pay less for virtual visits:
Texas doesn’t mandate private payer parity by law, but many insurers voluntarily pay equal rates for tele-mental health after COVID demonstrated effectiveness.
Medicare reimburses NPs at 85% of physician rates when billing under their own NPI. If a psychiatrist gets paid $100 for a visit, an NP gets $85 for the same service. This applies to Medicare and often carries over to other payers.
Some practices use ‘incident to’ billing (billing NP visits under physician NPI at 100% rate), but this requires strict criteria — physician on-site, established patient, existing plan of care. It’s generally not feasible for telehealth or independent psychiatric practice.
What this means: On telehealth platforms, PMHNP visits generate slightly less revenue per appointment than psychiatrist visits, though NP salaries are typically lower than MD salaries, which can balance the economics from a platform perspective.
Here’s where provider economics get interesting.
Many solo psychiatrists or PMHNPs try to build their own patient base through:
Reality check: When you factor in all costs — agency/consultant fees, ad spend, staff time qualifying leads, no-shows from cold marketing leads, months of testing before profitability — acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+.
For Google Ads specifically, a realistic cost per booked patient is $200-400+ after accounting for click costs, conversion rates, and no-shows.
The platform value proposition: Klarity Health uses a pay-per-appointment model. You pay a standard listing fee per new patient lead, but:
Frame it as risk elimination: Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. That’s guaranteed ROI versus gambling on marketing channels you may not have expertise in.
Can DIY marketing eventually be cost-effective? Sure — if you have the budget, expertise, and patience. But for most providers (especially those starting out or scaling quickly), a platform that handles patient acquisition removes the financial risk entirely.
Every state with controlled substance prescribing requires checking the Prescription Drug Monitoring Program database before prescribing. State-specific requirements:
Most state PDMP systems are accessible online. Some integrate with EHR systems. Factor in 2-3 minutes per prescription for PDMP checks in your workflow.
Telehealth visits are audited similarly to in-person. Your documentation must support:
E/M coding rules: Since 2021, office visit codes are based on time or medical decision-making complexity. A straightforward 15-minute anxiety med refill might be 99213. A complex case with multiple medication adjustments or therapy integration could justify 99214.
For psychiatrists: Consider the Interstate Medical Licensure Compact (IMLC). Texas and Illinois participate. California and New York don’t. IMLC expedites getting licensed in multiple states — useful if you want to practice telehealth broadly.
For PMHNPs: Multi-state practice is more complex because you need to understand each state’s practice authority. The Nurse Licensure Compact (NLC) exists for basic RN licenses, but prescriptive authority rules are state-specific. An NP with licenses in multiple states may have independent authority in one state (like NY) but need physician collaboration in another (like PA).
Platform benefit: Telehealth platforms like Klarity handle credentialing complexity and match you with patients in states where your licenses and practice authority align with the clinical requirements.
Anxiety disorders are the most common mental health conditions in America. The provider shortage is real:
Telehealth expands access to underserved areas. A psychiatrist in New York City can treat patients in rural upstate New York. A PMHNP with Texas and California licenses can serve both markets from one location.
The business opportunity: Provider shortages mean patient demand exceeds supply. Platforms with qualified, credentialed providers can fill that gap efficiently. You’re not competing for patients — you’re meeting unmet need.
Can I prescribe benzodiazepines via telehealth as a psychiatrist?
Yes, through at least December 2026 under extended federal COVID-era flexibilities. You can initiate benzodiazepine treatment for a new anxiety patient entirely via video visit, no initial in-person visit required. State PDMP checks still apply.
Can PMHNPs prescribe Xanax or other controlled anxiety meds?
Yes, but it depends on your state. In Full Practice Authority states (NY, AZ, OR, WA, etc.), you can prescribe independently. In states requiring collaboration (TX, PA, FL, CA for new NPs), you need a physician agreement that authorizes controlled substance prescribing. In Texas specifically, you’d need your prescriptive authority agreement to include benzodiazepines, which it typically does for psychiatric NPs.
What happens to telehealth prescribing after 2026?
The DEA is crafting permanent regulations expected by late 2026. These may include a special telemedicine registration or some return to in-person requirements for controlled substances. Until then, current flexibilities remain. Stay updated through DEA and professional organization communications.
Do I need separate licenses to prescribe in multiple states via telehealth?
Yes. You must be fully licensed in the state where the patient is located at the time of the telehealth visit. Some states (like Florida) offer telehealth provider registrations for out-of-state physicians, but these typically don’t allow controlled substance prescribing. For full practice authority including controlled prescriptions, you need full licensure in that state.
How does reimbursement compare between in-person and telehealth for anxiety treatment?
In most states with parity laws, insurance pays the same. Medicare currently pays equal rates for telehealth through at least 2024-2025. Medicaid in most states has permanent telehealth parity. Some commercial insurers in states without parity laws may pay slightly less for telehealth, but this is increasingly rare for mental health services.
If I’m an NP in a restricted state, can I work on a telehealth platform?
Yes, but the platform must provide or facilitate the required physician collaboration. For example, if you’re a Pennsylvania PMHNP, you’d need a collaborative agreement with a PA-licensed physician. Some platforms have staff psychiatrists who serve as collaborators for NPs in restricted states. Others require you to bring your own collaboration relationship.
What’s the difference between Psychology Today, Zocdoc, and Klarity for growing my practice?
Psychology Today charges a monthly directory listing fee ($29.95-$40/month) and you compete with hundreds of providers on the same search pages. Patients find you but you handle all intake, scheduling, and billing. Zocdoc charges per booking ($35-100+ per new patient) plus monthly fees, and you’re still competing in a crowded directory. Klarity operates on a pay-per-appointment model with pre-qualified patients matched to your specialty — similar per-patient cost to Zocdoc but with built-in telehealth infrastructure, insurance billing support, and no ongoing monthly fees if you’re not seeing patients. The key difference: directories send you leads you have to convert and manage; platforms like Klarity handle the full patient acquisition and operational workflow.
If you’re a psychiatrist or PMHNP looking to treat anxiety patients via telehealth, you have two paths:
Build your own practice:
Join a platform like Klarity:
The honest comparison: DIY marketing can be cost-effective long-term if you have expertise and budget. But platform practice removes the risk entirely — you’re paying for qualified patient flow only when it materializes. For most providers, especially those without marketing backgrounds, that’s the smart economic choice.
Ready to explore how Klarity Health’s provider network works? We handle patient acquisition, credentialing, billing, and telehealth infrastructure so you can focus on what you do best — treating anxiety and getting patients back to their lives.
HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (Jan 2, 2026). Available at: www.hhs.gov
Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (2024 Statutes). Available at: www.flsenate.gov and www.flsenate.gov
California Board of Registered Nursing – AB 890 Implementation FAQs (Updated 2024). Available at: rn.ca.gov
NPNY Announcement – ‘NP Modernization Act Passes in NY’ (April 9, 2022). Available at: npny.enpnetwork.com
TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (2025). Available at: therathink.com
Find the right provider for your needs — select your state to find expert care near you.